Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction

By sjmartinez • June 16, 2023

Swat SA, Xu H, Allen LA, Greene SJ, DeVore AD, Matsouaka RA, Goyal P, Peterson PN, Hernandez AF, Krumholz HM, Yancy CW, Fonarow GC, Hess PL; American Heart Association’s Get With the Guidelines–Heart Failure (GWTG-HF) Program. Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2023 Jun 2:S2213-1779(23)00232-9. doi: 10.1016/j.jchf.2023.04.015. Epub ahead of print. PMID: 37318420.

Tags: Cardiology/Epi, heart failure hospitalization, Heart failure with reduced ejection fraction, left ventricular dysfunction, Prescribing patterns, Publications, quality of care

Surviving the Odds: Primary Cardiac Lymphoma With Locoregional Lymph Node Involvement Complicated by Pericardial Effusion and Arrhythmia

Bachour K, Shah S, Reichl A, Chia J, Shabsovich DS, Castillo A, Cho G. Surviving the Odds: Primary Cardiac Lymphoma With Locoregional Lymph Node Involvement[...]

Aortic valve calcium as a novel risk marker for kidney function deterioration: The MESA study

Abdollahi A, Sani MM, Shabani M, Matuck BS, Blaha MJ, Wu CO, Ambale-Venkatesh B, Budoff MJ, Strom JB, Rotter JI, Post WS, Blumenthal RS, Bluemke[...]

Mutual Regulation of Cardiovascular and Hematopoietic Development

Liu N, Nakano H, Nakano A. Mutual Regulation of Cardiovascular and Hematopoietic Development. Curr Cardiol Rep. 2025 Apr 22;27(1):86. doi: 10.1007/s11886-025-02236-5. PMID: 40261519.